The following are ongoing Alzheimer’s Disease clinical trials in Canada:
Study to Evaluate Efficacy of ALZ-801 in APOE4/4 Early AD Subjects (APOLLOE4)
Open Label Extension of Phase 2b/3 Study ANAVEX2-73-AD-004 (ATTENTION-AD)
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer’s Disease (REFOCUS-ALZ)
Research Study Investigating Semaglutide in People With Early Alzheimer’s Disease (EVOKE)
A Research Study Investigating Semaglutide in People With Early Alzheimer’s Disease (EVOKE Plus)